Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the San Diego-based company’s total funding to date up to $46.3 million.

The benchtop machine will release 700 sq ft area and reduce the workforce to just one, thus saving operational costs for labs.